Description: Objective: assessing the economic impact of orphan drugs legislation on the drug R&D for rare diseases and the economic challenges to the industry, the investors and the health insurance system.
innovation (7909) economics (1251) drugs (1027) r&d (463) orphan (226) rare disease (97) rare cancer (15) genetic disease (14)
INNOVATION & INEQUALITY
CONTACT: [email protected]
PRIVACY ET COOKIES / LEGAL NOTICE